WHO SHOULD RECEIVE BLOOD

• WHOLE BLOOD To restore blood volume and oxygen-carrying capacity Symptomatic anemia with large volume deficit
• PACKED RBC To restore oxygen- carrying capacity Symptomatic anemia
• WASHED RBC To remove plasma proteins Symptomatic anemia on patients with severe allergic or anaphylactic conditions.
• LEUKO-REDUCED/LEUKO-POOR COMPONENTS To minimize exposure of patients to donor leukocytes Prevents febrile transfusion reaction caused by antibodies against WBCs, to reduced CMV transmission.
• NEOCYTE-ENRICHED RBC To prolong time between transfusions in chronically transfusion-dependent patients(e.g. sickle cell anemia or thalassemia
• FROZEN/DEGLYCEROLIZED RBC Prevention of non-hemolytic febrile transfusion reactions, plasma allergies or exposure to cytomegalovirus especially in patients with rare phenotype; autologous.
• IRRADIATED BLOOD COMPONENTS To inactivate the replicative machinery of the donor leukocytes To prevent graft-vs-host-disease, for newborns and patients with marrow transplants
• RANDOM DONOR PLATELETS Bleeding due to quantitative or qualitative platelet defect
• SINGLE DONOR PLATELETS Bleeding due to quantitative or qualitative platelet defect, prevention of HLA alloimmunization
• FRESH FROZEN PLASMA To replace plasma proteins and all coagulation factors except platelets who are bleeding, or at risk of bleeding; multiple coagulation factor deficiency.
• SINGLE DONOR PLASMA To treat hypovolemic shock or severe burns.
• CRYOPRECIPITATE Treatment of patients with von Willebrand’s disease, hemophilia A(factor viiidefiency) or hypofibrinogenemia who are bleeding, or at risk of bleeding; disseminated intravascular coagulation.
• GRANULOCYTE CONCENTRATES To elevate the leukocyte count in patients with neutropenia or granulocyte dysfunction who are suffering from, or at risk of, a lifethreatening infection; Neutropenia with infection unresponsive to antibiotics.
• FACTOR CONCENTRATES Specific coagulation factor deficiencies
• PROTHROMBIN COMPLEX Treatment of patients with a deficiency of factors II,VII,IX or X who are bleeding or at risk of bleeding.
• IMMUNE SERUM GLOBULIN (ISG) Patients with congenital hypogammaglobulinemia(given monthly).
• VOLUME EXPANDERS Patients with hemorrhagic shock and burn patients
• ALBUMIN (5%) To increase blood volume while maintaining colloidal oncotic pressure